Navigation Links
Babcock Grasper

ProductsBabcock Grasper
Company Mediflex Surgical Products
Item Babcock Grasper
Features 
  • One Piece or Modular
  • With rachet
  • 5mm diameter
  • 33cm or 45cm length
  • Insulation
  • Flush ports
  • Rotating shafts
  • Standard stainless steel handles
  • Description The Featured Products are kept in stock at Mediflex and are offered as 1-piece or modular in regular or extra long lengths. All come equipped with insulation, flush ports, rotating shafts, ratchets (where applicable) and standard stainless steel handles.
    Info Mediflex Surgical Products
    Customer Service: (800) 879-7575
    Web site: http://www.mediflex.com/

    Related medicine products :

    1. 10mm Babcock Grasper
    2. Babcock-DeBakey Forceps
    3. 10 mm Babcock-Debakey Forceps
    4. Babcock Grasping Forceps, Tungsten-Carbide
    5. Babcock Grasping Forceps
    6. Babcock Grasping Forceps w/o Debakey Jaws
    7. Atraumatic Spring Jaw Babcock Forceps
    8. Snap-In Snap-Out®-II Babcock Grasping Forceps Insert
    9. Optima III Noninsulated Babcock Grasper, with ratchet
    10. Optima III Noninsulated Babcock Grasper, without ratchet
    11. Shutt® Small Joint Graspers
    Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
    10 (mm) smooth platform; Serrated handle in stainless steel....
    ... first digital solution designed specifically for cardiologists ... outside cardiology. From the server core to ... combined expertise in both cine film and ... work the way they want, wherever they ...
    ... Medison SonoAce 9900 is ... based ultrasound system, with ... is DICOM compatible, designed ... general imaging, obstetrics, gynecology, ...
    Medicine Products:
    (Date:10/22/2014)... 2014 Although there are only 24 hours in ... people who have trouble finding time within their busy schedules for ... long periods of time to get in shape. Here are five ... the go. , Change Up Your Commute , Consider riding ... add some exercise into your daily routine. If you must use ...
    (Date:10/22/2014)... 2014 Richard Carlson, Managing Partner of ... with over 25 years experience. Mr. Carlson is ... areas related to EDI, B2B Commerce, RFID and Internet/Intranet ... Advisory Board member for Pharmaceutical Commerce Magazine and a ... Group is a management and technology consulting firm focused ...
    (Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... be showing a genetic propensity for obesity as toddlers, a ... linked to increased body fat, but the same genes in ... researchers said. At 1 year, kids with these genes ... however, these genes were linked to excessive weight gain, the ...
    (Date:10/22/2014)... Oct. 21, 2014 (HealthDay News) -- Two sisters in ... heart damage. Ilina and Medha Krishen use electronic ... sounds of trouble in breathing patterns or heartbeats. ... in Michigan, wanted to find a way to detect ... pollutants. Using an electronic stethoscope, Ilina recorded one breath ...
    (Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... vitro fertilization (IVF) -- the incubation of embryos in a ... inside the vagina, new research suggests. Scientists from the ... INVOcell, might sharply cut costs for pricey IVF procedures among ... to those who don,t live near big-city assisted reproduction centers, ...
    Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
    ... SEGUNDO, Calif., Nov. 3 DaVita Inc. (NYSE:,DVA) ... 30, 2008. Net,income for the three and nine ... $275.8 million, or $0.89 per share and $2.59 ... Net income for the three months ended September ...
    ... say a home safety review could cut odds of fractures ... News) -- Former first lady Nancy Reagan and Democratic ... hip injuries. And on Friday, author Studs Terkel died, following ... decline. , Such news, experts say, should be a reminder ...
    ... be changed , , SATURDAY, Nov. 1 (HealthDay News) -- ... according to a UCLA study of almost 1,500 patients ... and need to be treated accordingly. , The UCLA ... approach needs to be changed. , "We have shown ...
    ... American Academy of Otolaryngology Head and Neck ... guideline to help healthcare practitioners identify and treat ... of the most common underlying conditions that cause ... BPPV, the most common vestibular (inner ear) disorder ...
    ... Entrees Provide Easy, Delicious, Relief During ... Stressful Election Times, EDISON, N.J., Oct. ... isn,t much time to think about what to eat,let alone cook an ... stress with their delicious and easy gourmet,Indian cuisine that can be made ...
    ... wardrobe could have been spent on ... healthcare, housing, ... the http://www.DressLikePalin.com website this week, scores offering,their views on ... National Committee famously spent on the wardrobe for Gov. Sarah,Palin., ...
    Cached Medicine News:Health News:DaVita 3rd Quarter 2008 Results 2Health News:DaVita 3rd Quarter 2008 Results 3Health News:DaVita 3rd Quarter 2008 Results 4Health News:DaVita 3rd Quarter 2008 Results 5Health News:DaVita 3rd Quarter 2008 Results 6Health News:DaVita 3rd Quarter 2008 Results 7Health News:DaVita 3rd Quarter 2008 Results 8Health News:DaVita 3rd Quarter 2008 Results 9Health News:DaVita 3rd Quarter 2008 Results 10Health News:DaVita 3rd Quarter 2008 Results 11Health News:DaVita 3rd Quarter 2008 Results 12Health News:DaVita 3rd Quarter 2008 Results 13Health News:DaVita 3rd Quarter 2008 Results 14Health News:DaVita 3rd Quarter 2008 Results 15Health News:DaVita 3rd Quarter 2008 Results 16Health News:DaVita 3rd Quarter 2008 Results 17Health News:Falls Are Leading Cause of Injury to Seniors 2Health News:Tailored Treatment Boosts Kidney Cancer Survival 2Health News:ENT doctors release national guideline on treatment for common cause of dizziness 2Health News:ENT doctors release national guideline on treatment for common cause of dizziness 3Health News:Easy Ethnic Election 2Health News:Tens of Thousands View DressLikePalin Web Site 2Health News:Tens of Thousands View DressLikePalin Web Site 3
    (Date:10/22/2014)... , Oct. 22, 2014 WHEN: Wednesday, October ... complimentary registration available at: http://bit.ly/1yStiU9 ... Vidyasekar and Visionary Innovation Research Group Senior ... electricity, self-assembling materials, nanobots and flexible electronics ... will transform our lives in the coming ...
    (Date:10/22/2014)... LA JOLLA, Calif. , Oct. 22, ... RGLS ), a biopharmaceutical company leading ... targeting microRNAs, today announced that it has ... from an ongoing clinical study evaluating RG-101, ... for the treatment of hepatitis C virus ...
    (Date:10/20/2014)... ENGLEWOOD, Colo. , Oct. 20, 2014 /PRNewswire/ ... Inc. (NYSE MKT: AMPE), today announced that its ... the clinical and research potential for its novel ... oxidation-reduction potential (ORP) in the body in response ... clinical value of ORP as a clinical marker ...
    Breaking Medicine Technology:Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5